Hermann and coworkers explored the immunophenotypic features of CD34+/CD38− cells purified from a large set of AML and CML patients and observed that CD123, as well as CD33, are clearly more expressed on leukemic cells compared to the normal CD34+/CD38− counterpart [30]. This evidence concerns the gene CD34 and acute myeloid leukemia.